Low serum magnesium level is associated with microalbuminuria in Chinese diabetic patients

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Xu, Baihui ^a   Sun, Jichao ^a   Deng, Xinru ^a   Huang, Xiaolin ^a   Sun, Wanwan ^a   Xu, Yu ^a   Xu, Min ^a   Lu, Jieli ^a   Bi, Yufang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; LIPID; MAGNESIUM;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHINA; CHINESE; COMMUNITY ASSESSMENT; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; LIPID BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC PARAMETERS; MICROALBUMINURIA; MIDDLE AGED; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; URINALYSIS; URINARY ALBUMIN CREATININE RATIO;

EID: 84884221355     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/580685     Document Type: Article

References (24)

1. Xu J., Xu W., Yao H., Sun W., Zhou Q., Cai L., Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the chinese northeast population. PLoS ONE 2013 8 e56750
2. Guerrero-Romero F., Rodríguez-Morán M., Low serum magnesium levels and metabolic syndrome. Acta Diabetologica 2002 39 4 209 213 2-s2.0-0036904258 10.1007/s005920200036
3. Simmons D., Joshi S., Shaw J., Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Research and Clinical Practice 2010 87 2 261 266 2-s2.0-74449092660 10.1016/j.diabres. 2009.11.003
4. Kim D. J., Xun P., Liu K., Loria C., Yokota K., Jacobs D. R. Jr., He K., Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010 33 12 2604 2610 2-s2.0-79251647026 10.2337/dc10-0994
5. Viberti G. C., Jarrett R. J., Hill R. D., Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. The Lancet 1982 1 8287 1430 1432 2-s2.0-0020045025
6. Dinneen S. F., Gerstein H. C., The association of microalbuminuria and mortality in non-insulin- dependent diabetes mellitus: a systematic overview of the literature. Archives of Internal Medicine 1997 157 13 1413 1418 2-s2.0-0030746637
7. Corsonello A., Ientile R., Buemi M., Cucinotta D., Mauro V. N., Macaione S., Corica F., Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. American Journal of Nephrology 2000 20 3 187 192 2-s2.0-0033947880
8. Mirrahimi B., Hamishehkar H., Ahmadi A., The efficacy of magnesium sulfate loading on microalbuminuria following SIRS: one step forward in dosing. Daru 2012 20, article 74
9. Sales C. H., Pedrosa L. F. C., Lima J. G., Lemos T. M. A. M., Colli C., Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes. Clinical Nutrition 2011 30 3 359 364 2-s2.0-79957577686 10.1016/j.clnu.2010.12.011
10. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus 1999 Geneva, Switzerland World Health Organization
11. Eknoyan G., Hostetter T., Bakris G. L., Hebert L., Levey A. S., Parving H.-H., Steffes M. W., Toto R., Willis K., Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). American Journal of Kidney Diseases 2003 42 4 617 622 2-s2.0-0141819203 10.1016/S0272-6386(03)00826-6
12. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization, 1999
13. Levy J. C., Matthews D. R., Hermans M. P., Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 12 2191 2192 2-s2.0-0031737373
14. Levey A. S., Bosch J. P., Lewis J. B., Greene T., Rogers N., Roth D., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals of Internal Medicine 1999 130 6 461 470 2-s2.0-0033574249
15. Allegra A., Corsonello A., Buemi M., D'Angelo R., Di Benedetto A., Bonanzinga S., Cucinotta D., Ientile R., Corica F., Plasma, erythrocyte and platelet magnesium levels in type 1 diabetic patients with microalbuminuria and clinical proteinuria. Journal of Trace Elements in Medicine and Biology 1997 11 3 154 157 2-s2.0-0030730030
16. Arslanoglu I., Gunoz H., Bundak R., Saka N., Hypomagnesaemia in childhood IDDM and risk of nephropathy. Diabetologia 1995 38 5, article 629 2-s2.0-0028920141
17. Zargar A. H., Bashir M. I., Masoodi S. R., Laway B. A., Wani A. I., Khan A. R., Dar F. A., Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Medical Journal 2002 23 5 539 542 2-s2.0-0036279060
18. Zhang W., Iso H., Ohira T., Date C., Tamakoshi A., Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study. Atherosclerosis 2012 221 2 587 595 2-s2.0-84858699696 10.1016/j.atherosclerosis.2012.01.034
19. Gerstein H. C., Mann J. F. E., Yi Q., Zinman B., Dinneen S. F., Hoogwerf B., Hallé J. P., Young J., Rashkow A., Joyce C., Nawaz S., Yusuf S., Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Journal of the American Medical Association 2001 286 4 421 426 2-s2.0-0035948631
20. McCarty M. F., Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Medical Hypotheses 2005 64 3 619 627 2-s2.0-11144343274 10.1016/j.mehy.2003.10.034
21. 2+ transports in TAL of mouse nephron: cross-potentiation with AVP. American Journal of Physiology 1993 265 3 F361 F369 2-s2.0-0027489272
22. Hsu C.-C., Chang H.-Y., Huang M.-C., Hwang S.-J., Yang Y.-C., Tai T.-Y., Yang H.-J., Chang C.-T., Chang C.-J., Li Y.-S., Shin S.-J., Kuo K. N., Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study. Diabetes Care 2011 34 4 982 987 2-s2.0-79956213390 10.2337/dc10-1718
23. Shao N., Kuang H. Y., Wang N., Relationship between oxidant/antioxidant markers and severity of microalbuminuria in the early stage of nephropathy in type 2 diabetic patients. Journal of Diabetes Research 2013 2013 6 10.1155/2013/232404 232404
24. Altura B. T., Altura B. M., Endothelium-dependent relaxation in coronary arteries requires magnesium ions. British Journal of Pharmacology 1987 91 3 449 451 2-s2.0-0023277187